EP Patent

EP1756137A4 — DIAGNOSTIC AND THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING PTEN AND BREAST CANCER

Assigned to University of Texas System · Expires 2007-10-31 · 19y expired

What this patent protects

Patent listed against neratinib-maleate.

Drugs covered by this patent

neratinib-maleate (NERATINIB MALEATE)

Patent Metadata

Patent number: EP1756137A4
Jurisdiction: EP
Classification: —
Expires: 2007-10-31
Drug substance claim: No
Drug product claim: No
Assignee: University of Texas System
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.